Overexpression of Grb2-associated binder 2 in human lung cancer

International Journal of Biological Sciences

Volumn 7, Issue 5, 2011, Pages 496-504

  Xu, Xiu Li ^a   Wang, Xia ^a   Chen, Zhao Li ^b   Jin, Min ^b   Yang, Wu ^b   Zhao, Guo Fan ^a   Li, Jun Wen ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Key Laboratory of Risk Assessment and Control for Environment and Food Safety   (China)

Author keywords

Gab2; Immunohistochemistry; Lung cancer; Quantitative real time PRC; Western blot

Indexed keywords

EID: 79955754246     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.496     Document Type: Article

References (23)

1. Liu Y, Rohrschneider L.R. The gift of Gab. FEBS Lett. 2002; 515: 1-7.
2. Horst B, Gruvberger-Saal SK, Hopkins BD, et al. Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol. 2009; 174: 1524-1533.
3. Gu H, Neel BG. The Gab in signal transduction. Trends Cell Biol. 2003; 13: 122-130.
4. Daly RJ, Gu H, Parmar J, et al. The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene. 2002; 21: 5175-5181.
5. Bocanegra M, Bergamaschi A, Kim YH, et al. Focal amplification and oncogene dependency of GAB2 in breast cancer. On-cogene. 2010; 29: 774-9.
6. Ke Y, Wu D, Princen F, et al. Role of Gab2 in mammary tu-morigenesis and metastasis. Oncogene. 2007; 26: 4951-4960.
7. Sattler M, Mohi MG, Pride YB, et al. Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell. 2002; 1: 479-492.
8. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001; 29: e45.
9. Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 2000; 89: 2637-2645.
10. Wöhrle FU, Daly RJ, Brummer T. Function, regulation and pathological roles of the Gab/DOS docking proteins. Cell Commun Signal. 2009; 7: 22.
11. Wada T, Nakashima T, Oliveira-dos-Santos AJ, et al. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat Med. 2005; 11: 394-9.
12. Sun J, Pedersen M, Rönnstrand L. Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. J Biol Chem. 2008; 283: 27444-27451.
13. Fleuren ED, O'Toole S, Millar EK, et al. Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development. Int J Cancer. 2010; 127: 1486-1492.
14. Brown LA, Kalloger SE, Miller MA, et al. Amplification of 11q13 in ovarian carcinoma. Genes Chromosomes Cancer. 2008; 47: 481-9.
15. Lee SH, Jeong EG, Nam SW, et al. Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas. Pathology. 2007; 39: 326-9.
16. Zatkova A, Schoch C, Speleman F, et al. GAB2 is a novel target of 11q amplification in AML/MDS. Genes Chromosomes Cancer. 2006; 45: 798-807.
17. Ikram MA, Liu F, Oostra BA, et al. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis. Biol Psychiatry. 2009; 65: 995-9.
18. Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007; 54: 713-720.
19. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000; 60: 1968-1973.
20. Ormandy CJ, Musgrove EA, Hui R, et al. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat. 2003; 78: 323-335.
21. Bekri S, Adélaïde J, Merscher S, et al. Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma. Cytogenet Cell Genet.1997; 79: 125-131.
22. Lambros MB, Fiegler H, Jones A, et al. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization. J Pathol. 2005; 205: 29-40.
23. Maulik G, Madhiwala P, Brooks S, et al. Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer. J Cell Mol Med. 2002; 6: 539-553.